Literature DB >> 17412312

Local adipose tissue depots as cardiovascular risk factors.

Sébastien Thalmann1, Christoph A Meier.   

Abstract

Obesity is associated with increased cardiovascular morbidity and mortality. Although obesity-associated hypertension, dyslipidemia and insulin resistance account in part for this association, it becomes increasingly apparent that a systemic and local pro-inflammatory response of adipose tissue might also be a contributing factor. White adipose tissue (WAT) is a highly active organ secreting various peptides such as cytokines, chemokines and hormone-like proteins. Besides the visceral and subcutaneous depots, WAT is also found in the close vicinity of blood vessels (perivascular adipose tissue), where it secretes cytokines such as interleukin-1, tumor necrosis factor alpha, pro-atherogenic chemokines, and pro-angiogenic peptides. These factors appear to contribute directly to alterations of the function and structure of the vascular wall, including chronic inflammation, alterations of vascular tone, proliferation of smooth muscle cells, neo-angiogenesis and hence to the development of atherosclerosis and cardiovascular complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412312     DOI: 10.1016/j.cardiores.2007.03.008

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  52 in total

1.  The adventitia: the outs and ins of vascular disease.

Authors:  Patrick J Pagano; David D Gutterman
Journal:  Cardiovasc Res       Date:  2007-07-16       Impact factor: 10.787

2.  Adipocyte-derived factor reduces vasodilatory capability in ob-/ob- mice.

Authors:  Lusha Xiang; Robert L Hester
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

3.  Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodeling.

Authors:  Christine R Mauro; Kui Ding; Hui Xue; Ming Tao; Alban Longchamp; Michael Belkin; Bruce S Kristal; C Keith Ozaki
Journal:  J Vasc Surg       Date:  2014-09-26       Impact factor: 4.268

4.  Impact of the AGTR1 A1166C polymorphism on subcortical hyperintensities and cognition in healthy older adults.

Authors:  Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Thomas E Conturo; David F Tate; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Erbil Akbudak; Robert H Paul
Journal:  Age (Dordr)       Date:  2014-07-01

5.  Sex differences in the regulation of porcine coronary artery tone by perivascular adipose tissue: a role of adiponectin?

Authors:  Abdulla A Ahmad; Michael D Randall; Richard E Roberts
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

6.  Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall: a potential role in vascular stiffness and atherosclerosis.

Authors:  Kelly J Shields; Donna Stolz; Simon C Watkins; Joseph M Ahearn
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

Review 7.  Vasodilator signals from perivascular adipose tissue.

Authors:  Maik Gollasch
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

8.  Attenuated adiposopathy in perivascular adipose tissue compared with subcutaneous human adipose tissue.

Authors:  Christine R Mauro; Godfrey Ilonzo; Binh T Nguyen; Peng Yu; Ming Tao; Ian Gao; Michael A Seidman; Louis L Nguyen; C Keith Ozaki
Journal:  Am J Surg       Date:  2013-01-23       Impact factor: 2.565

Review 9.  Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.

Authors:  Claire Arnaud; Maurice Dematteis; Jean-Louis Pepin; Jean-Philippe Baguet; Patrick Lévy
Journal:  Semin Immunopathol       Date:  2009-04-29       Impact factor: 9.623

10.  Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity.

Authors:  Meredith Kohr Owen; Frank A Witzmann; Mikaela L McKenney; Xianyin Lai; Zachary C Berwick; Steven P Moberly; Mouhamad Alloosh; Michael Sturek; Johnathan D Tune
Journal:  Circulation       Date:  2013-05-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.